Ch 14 (lesson 17): Late life and Neurocognitive Disorders Flashcards
aging- what is old?
- in US, aging is dreaded
- elderly not revered as in other cultures
- 65 + considered “Old”
- 12.4% (35 mill) 65 +
- young-old: 65-74, old: 74-84, oldest: 85+
myths about late life
- aging inolves inevitible cognitive decline
- sever cog probs don’t occur for most
- mild declines common
- late life is a sad time/ most elderly depressed
- older ppl report less neg emotion
- more brain activation in key areas when viewing pos images
- late life is lonely
- some less likely to ddevelop new friendships
- social selectivity- focus more on relationships that matter most to us
- older people lose interest in sex
- sexual activity don’t decrease from mid to late life for most
Late life problems- probs multiply w age
- physical decline and disabilities
- sensory and neurological deficits
- loss of loved ones
- social stresses such as stigmatizing attitudes towards elderly
- 80% have 1+ major medical condition
late life problems- sleep disturbances increase w age
sleep deteriorates w age
- insomnia
- sleep apnea
late life problems- medical treatment
- chronic probs instead of curable disorders
- polypharmacy: practice of prescribing multiple drugs to patients
- psychoactive drugs usually tested on younger participants
three kinds of effects in research of aging people
- age effects
- cohort effects
- time-of-measurement effects
age effects
the effects of being a certain age (eg getting social security)
cohort effects
effects of having grown up during particular time (eg: frugality increased among those who lived during great depression)
not to be confused w age effects
time-of-measurements effects
effects of testing people at particular time in history (eg: in 1990s ppl became more frank about sexuality in surveys as media discussion of sexuality increased)
types of research designs
- Cross-sectional studies
- Longitudinal studies
Cross-sectional studies
- researcher tests different age groups at one point in time
- fails to give info about how ppl change over time/ as they age
Longitudinal studies
- researcher retests same group of ppl w same measures at diff points in time
- may extend over several years or decades
- attrition is a potential prob-
- attrition = ppl dropping out
- selective mortality (attrition due to death) can lead to biased sample– sample left represent healthy people, can’t draw conclusions about unhealthy people
- time of measurement can also be confused w aging effects
Neurocognitive Disorder in Late Life
- most elderly do not have cog disorders
- prevalence has decreased over last 15
most common:
- Dementia
- deterioration of cog function
- Delirium
- state of mental confusion
psychological disorders in older adults
every single disorder is less common in elderly people than younger adults
- most people with disorder later in life are experiencing a continuation of a disorder they’ve previously had
- older adults may be uncomfortable acknowledging/ disclosing mental health problems
- people with psych disorders at risk of dying earlier for variety of reasons
treating psych disorders in elderly
- psychotherapy
- be careful of side effects of meds, but they can be effective
- caregiver, if cog decline
Dementia
- Deterioration of cog func
- impairs social/occupational func
- progresses over time
- begins w forgetting recent events
- deficits can be detected before impairment is obvious
- Mild cog impairment develops slowly, major happens quickly
DSM-5 2 categories of Dementia
differentiated by ability to live independently:
- mild neurocognitive disorder (mild cog impairment)
- Major neurocognitive disorder (dementia)
DSM- 5 Neurocognitive disorders
- Delirium
- Neurocognitive disorder: specify mild or major
- Neurocog disorder assoc. w Alzheimer’s disease
- ” “ fronto-temporal lobar degeneration
- ” “ vascular disease
- ” “ traumatic brain injury
- ” “ Lewy body disease
- ” “ Parkinson’s disease
- ” “ HIV infection
- ” “ substance use
- ” “ Huntington’s diseease
- ” “ prion disease
- other specified neurocog disorder
DSM-5 Criteria for Mild Neurocog Disorder
- Minor cog decline from previous levels in 1+ domains based on both of the following:
- concerns of patient, close other, clinician
- neurocog performance below appropriate norms (btwn 3-16%) on formal testing/clinical eval
- The cog deficits don’t interfere w independence, even though greater effort, compensatory strategies, or accommodation may be required
- cog deficits don’t occur exclusively in context of a delirium and not due to another psych disorder
DSM-5 criteria for Major Neurocog disorder
- evidence of sig cog decline from prev levels in 1+ domain based on both:
- concernts of patient/other/clinician
- neurocog permorance below 3rd percentile on formal testing/ clinical eval
- Cog deficits interfere w independence
- cog deficits don’t occur exclusively in context of a delirium and not due to psych disorder
Alzheimer’s Disease
- Alois Alzheimer 1906
- more than half dementia is alzheimers
- Irreversible brain tissue deterioration
- death w/in 12 years
- Usually begins w
- difficulty remembering recent events
- learning new material
- irritability
- as disease progresses
- language probs intensify, word-finding
- disorientation- time, place, identity confusion
- agitation
- depression
Brain changes in Alzheimers
- plaques
- beta-amyloid protein deposits outside neurons
- primarily found in frontal cortex
- Neurofibrillary tangles
- protein filaments composed of protein tau in axons of neurons
- primarily found in hippocampus
- measured using PET scans
- Plaques most dense in frontal cortex; tangles most dense in hippocampus
- loss of synapses for acetylcholinergic (Ach) and glutaminergic neurons
- as neurons die, atrophy of cerebral and entorhinal cortices and hippocampus
- enlargement of ventricles
Genetic factors- alzheimers
- heritability 79%
- ApoE4 allele: gene on chromosome 19
- one E4 increases risk 20%
- 2 E4 increases risk substantially more
- related to over-production of beta-amyloid plaques, loss of neurons in hippocampus and low glucose metabolism in cerebral cortex
- many genes related to alzheimers also related to immune func and cholestoral metabolism
- conditions that involve immune and inflammatory processes at greater risk for alzheimers
Environmental Factors- Alzheimers
- brain traumas from accidents/ injuries can increase risk
- smoking, being single, low social support, depression related to greater risk
- mediterranean diet, exercise, education, cog engagement predict lower risk
- Cognitive reserve
- using alt brain networks to compensate for disease
frontotemporal Dementia
- loss of neurons in frontal and temporal lobes
- memory not severely disrupted
- impairment of exec functions
- planning
- prob solving
- goal-directed behavior
- Difficulty recognizing and regulating emotion
- much more profound impact than alzheimers
- caused by multiple genetic pathways
- pick’s disease
- high levels of tau proteins
- rare, less than 1%
- begins in late 50’s progresses rapidly
- death occurs w/in 5 yrs
Vascular Demetia
- Typically from stroke (cardiovascular)
- clot forms and impairs circulation
- cells die
- risk factors
- smoking, high LDL cholesterol high BP
- Symptoms and severity can vaery greatly depending on type and location of stroke
- 7% develop dementia after first stroke, risk increases w recurrent strokes
Dementia w Lewy Bodies (DLB)
- lewy bodies: protein deposits that form in the brain (olfactory bulb and brain stem) and cause cog decline
- 2 subtypes
- w parkinsons
- no parkinsons
- Symptoms similar to parkinsons and Alzheimers
- shuffling gait
- loss of memory
- Symptoms
- fluctuating cog symptoms
- prominent visual hallucination
- intense dreams involving movement and vocalizing
less than 10% of dementia is DLB
Dementias caused by Disease/ injury
- Encephalitis (inflammation of brain tissue by viruses
- meningitis (inflammation of covering membranes by bacteria)
- HIV
- Head traumas
- Brain tumors
- Nutritional deficits (B-complex)
treatments for dementia- medications
- no drug reverses
- some drugs produce slightly less decline
- cholinesterase inhibitors (prevent breakdown of acetylcholine)
- donepezil (Aricept)
- Galantamine (Reminyl)
- Vitamin E, statins, nonsteroidal anti-inflammatory drugs have failed to find support
- preventive work focuses on processes involved in creation of amyloid from precursor protein
- antidepressents for depression
-antipsychotic meds for agitation
Psych treatments for dementia
- supportive psychotherapy for family and patient
- education about disease and care
- cog interventions when disease in early stages
- labeling drawers, appliances
- calendars, clocks, strategically placed notes
- exercise assoc w cog benefits
- music reduces agitation and disruptive behavior
Delirium
- Clouded state of consciousness
- extreme trouble focusing attention
- disturbances in sleep/wake cycle
- fragmented thinking
- speech rambling, incoherent
- disorientation
- perceptual disturbances
- memory impairments
- mood swings
- secondary to underlying medical condition
- detection of delirium important but often missed
- untreated, further cog decline and mortality may occur
dementia vs delirium
- dementia gradual deterioration — delirium rapid onset
- dementia decifits in short term memory – delirium trouble concentrating/ staying on train of thought
- dementia caused by disease processes that directly influence brain, delirium secondary to anther med condition
- dementia usually progressive and nonreversible– delirium fluctuations over course of day
- dementia treatment offers min benefit – delirium usually reversible by treating underlying condition, fatal if not treated
- dementia prevalence increases w age – prevalence highest in young very young and old
etiology of delirium
- drug intoxications and withdrawal reactions
- metabolic and nutritional imbalances (diabetes, thyroid dysfunction, kidney/liver failure, heart failure, malnutrition
- neurological disorders (dementia, head trauma, seizures
- stress of major surgery,
- physical immobility/ restraints are key risk factors
- usually has more than one cause
older adults vulnerable bc
- physical decline, susceptibility to chronic disease, medications, sensitivity to drugs
treatment of delirium
- beyond treating underlying medical conditions, most common treatment is atypical antipsychotic medication
- prevention- reduce risk factors in hospital settings such as sleep deprivation, immobility, dehydration, visual/hearing impairment